Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window

 Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, we hereby inform that the Trading Window of the Company shall remain closed for all the Designated Persons and their relatives with effect from July 01, 2022 till 48 hours after the financial results of the Company for the quarter ended June 30, 2022 becomes generally available information.
30-06-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Audited Standalone Financial Results Of The Company, For The Quarter And Year Ended March 31, 2022

 Audited Standalone Financial Results Of The Company, For The Quarter And Year Ended March 31, 2022
27-05-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Friday, May 27, 2022

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. May 27, 2022, have discussed the following matters: 1. Approval of Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2022 along with the Statutory Auditor's Report thereon. The Audit Reports were issued with unmodified opinion of the financial statements. 2. Appointment of M/s. Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2022-2023. 3. Approval of Draft Report of Board of Directors, Management Discussion & Analysis Report along with other supporting documents forming part of Annual Report for the financial year 2021-22. 4. Considered and took on record Secretarial Audit Report issued by M/s Kavita Khatri & Associates, Practicing Company Secretary.
27-05-2022
Bigul

Annual report for Chemo Pharma Laboratories Ltd. for FY-2022
27-05-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, May 27, 2022

 CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31, 2022 along with the Auditor's Report thereon. 2. To consider and appoint M/s Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2022-23
17-05-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to above and based on the intimation received from the Company''s Registrar and Share Transfer Agent ("RTA") Purva Sharegistry (India) Private Limited on April 18, 2022, we would like to inform that the Company has received a letter from the following shareholder regarding loss of share certificate(s) with a request for issue of duplicate share certificate(s) in lieu thereof.
18-04-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2022

 We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2022.
18-04-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Non-Applicability of Annual Secretarial Compliance Report for the year ended March 31, 2022 under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
07-04-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2022

 Please find enclosed compliance certificate for the financial year ended 31st March, 2022 pursuant to Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, for your reference and records.
07-04-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ended March 31, 2022 issued by Company's Registrar and Share Transfer Agent (RTA), i.e. M/s. Purva Sharegistry (India) Private Limited thereby confirming the compliances under the said regulation.
05-04-2022
Next Page
Close

Let's Open Free Demat Account